Gene expression changes induced by HIPEC in a murine model of gastric cancer

In Vivo

Volumn 26, Issue 1, 2012, Pages 39-45

  Graziosi, Luigina ^a   Mencarelli, Andrea ^a   Renga, Barbara ^a   Santorelli, Chiara ^a   Cantarella, Francesco ^a   Bugiantella, Walter ^a   Cavazzoni, Emanuel ^a   Donini, Annibale ^a   Fiorucci, Stefano ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Gastric cancer; HIPEC; MKN45 cells; NOD SCID mice; Peritoneal carcinomatosis

Indexed keywords

APC PROTEIN; CARBOSSI TERMINAL BINDING PROTEIN; CHEMOKINE RECEPTOR CXCR4; CISPLATIN; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA2 CHAIN; CYSTATIN F; K RAS PROTEIN; MITOMYCIN; PROTEIN; PROTEIN KINASE SYK; SMAD2 PROTEIN; SODIUM CHLORIDE; SOMATOSTATIN RECEPTOR 2; UNCLASSIFIED DRUG; V KI RAS2 KIRSTEN RAT SARCOMA VIRAL PROTEIN; VASCULOTROPIN RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER MODEL; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; MALE; MESENTERY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PERITONEUM METASTASIS; POLYMERASE CHAIN REACTION; SCID MOUSE; STOMACH CANCER; UPREGULATION;

EID: 84855375848     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Jemal A: Cancer statistics. CA Cancer J Clin 59: 225-249, 2009.
2. Japanese Gastric Cancer Association. In: Japanese Classification of Gastric Cancer Carcinoma. second English edition 1: 5-30, 1998.
3. Bando E: Intraoperative lavage for cytological examination in 1.297 patients with gastric carcinoma. Am J Surg 178: 256-262, 1999.
4. Bentrem D: The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol 12: 347-253, 2005.
5. Bonenkamp JJ: Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg 83: 672-674, 1996.
6. Burke EC: Peritoneal lavage cytology in gastric cancer: an independent predictor of outcome. Ann Surg Oncol 5: 411-415, 1998.
7. Kodera Y: Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol 72: 60-64, 1999.
8. Sugarbaker PH: Peritonectomy procedures. Ann Surg 221: 29-42, 1995.
9. Thiery JP: Epithelial mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
10. Chinnadurai G: The transcriptional corepressor CtBP: a foe of multiple tumor suppressors. Cancer Res 69: 731-734, 2009.
11. Korenaga D: Peritoneal collagen type IV concentration in adenocarcinoma of the gastrointestinal tract and its relationship to histological differentiation, metastasis, and survival. Surg Today 28: 780-786, 1998.
12. Yasumoto K: Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 66: 2181-2187, 2006.
13. Ingold B: Vascular CXCR4 expression - A novel antiangiogenic target in gastric cancer? PLoS One 5(4): e10087, 2010.
14. Karkkainen MJ: Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 19: 5598-5605, 2000.
15. Stacker SA: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2: 573-583, 2002.
16. Ni XF: Serum VEGFR-3 and survival of advanced gastric cancer patients treated with FOLFOX. World J Gastroenterol 16: 63-69, 2010.
17. Jüttner S: Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol 24: 228-240, 2006.